ARCUTIS BIOTHERAPEUTICS, INC. (ARQT)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
INTU Investors Have Opportunity to Lead Intuit Inc. Securities Fraud Lawsuit
Western Metallica Resources Corp. Announces Exclusivity and Binding Option Agreement for Nueva Celti Copper Project
New SEC Form for ResMed Inc.